Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study

Mauro Ragonese; Monica Larosa; Stefania Angotti; Stefania Annese; Laura Cruciani; Michela Dainelli; Giuseppe Lucisano; Giuseppe Prosperini; Michele Sacco; Enrica Salomone; Caterina Saponara; Roberta Semprini; Maria Chiara Rossi; Antonio Nicolucci

doi:10.1007/s13300-020-00902-1

Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study

Diabetes Therapy ◽

10.1007/s13300-020-00902-1 ◽

2020 ◽

Vol 11 (10) ◽

pp. 2283-2298

Author(s):

Mauro Ragonese ◽

Monica Larosa ◽

Stefania Angotti ◽

Stefania Annese ◽

Laura Cruciani ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching From Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+ Subgroup Analyses

Diabetes ◽

10.2337/db18-1057-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1057-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec ◽

Subgroup Analyses

Download Full-text

Real-World Clinical Outcomes of Type 2 Diabetes (T2D) Patients Switching from Insulin Glargine 100 U/mL (Gla-100) or Insulin Detemir (IDet) to Insulin Glargine 300 U/mL (Gla-300) or Insulin Degludec (IDeg)—DELIVER D+

Diabetes ◽

10.2337/db18-1056-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1056-P

Author(s):

SEAN D. SULLIVAN ◽

TIMOTHY S. BAILEY ◽

RONAN ROUSSEL ◽

FANG L. ZHOU ◽

ZSOLT BOSNYAK ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Detemir ◽

Insulin Degludec

Download Full-text

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study

Advances in Therapy ◽

10.1007/s12325-017-0651-3 ◽

2018 ◽

Vol 35 (1) ◽

pp. 43-55 ◽

Cited By ~ 12

Author(s):

Shaloo Gupta ◽

Hongwei Wang ◽

Neil Skolnik ◽

Liyue Tong ◽

Ryan M. Liebert ◽

...

Keyword(s):

Type 2 Diabetes ◽

Observational Study ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Retrospective Observational Study ◽

Real World Setting ◽

Dosing Patterns

Download Full-text

Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13345 ◽

2018 ◽

Vol 20 (9) ◽

pp. 2148-2158 ◽

Cited By ~ 33

Author(s):

Sean D. Sullivan ◽

Timothy S. Bailey ◽

Ronan Roussel ◽

Fang Liz Zhou ◽

Zsolt Bosnyak ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Comparative Effectiveness ◽

Basal Insulin ◽

Insulin Analogues ◽

Insulin Degludec

Download Full-text

PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

Value in Health ◽

10.1016/j.jval.2011.08.1325 ◽

2011 ◽

Vol 14 (7) ◽

pp. A475

Author(s):

M. Pawaskar ◽

Q. Li ◽

B. Hoogwerf ◽

M.W. Reynolds ◽

D.E. Faries ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Exenatide Bid

Download Full-text

Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real‐world patients with type 1 and type 2 diabetes

Journal of Diabetes Investigation ◽

10.1111/jdi.13559 ◽

2021 ◽

Author(s):

Junko Oya ◽

Tomoko Nakagami ◽

Yukiko Hasegawa ◽

Aki Katamine ◽

Yuichiro Kondo ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Clinical Outcomes ◽

Real World ◽

Insulin Degludec

Download Full-text

Abstract #1151: Lower Risk of Hypoglycemia and Less Health Care Utilization in Basal Insulintreated Patients with Type 2 Diabetes (T2D) After Switching to Insulin Glargine 300 UNITS/ML (GLA-300) VS Other Basal Insulins in Real-World Clinical Settings

Endocrine Practice ◽

10.1016/s1530-891x(20)44281-8 ◽

2017 ◽

Vol 23 ◽

pp. 317-318

Author(s):

Fang Liz Zhou ◽

Fen Ye ◽

Vineet Gupta ◽

Rishab Gupta ◽

Jennifer Sung ◽

...

Keyword(s):

Type 2 Diabetes ◽

Health Care ◽

Health Care Utilization ◽

Insulin Glargine ◽

Real World ◽

Lower Risk ◽

Care Utilization ◽

Clinical Settings

Download Full-text

2327-PUB: Real-World Patient-Reported Outcomes (PROs) with Insulin Glargine 300 U/ml (Gla-300) in Basal Bolus-Treated People with Type 2 Diabetes (T2DM): The MAGE Study

Diabetes ◽

10.2337/db19-2327-pub ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 2327-PUB ◽

Cited By ~ 1

Author(s):

ANN A. VERHAEGEN ◽

ANDRÉ SCHEEN ◽

KATHY C. ALEXANDRE ◽

JACQUES BRUHWYLER ◽

IDES M. COLIN

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Real World ◽

Patient Reported Outcomes ◽

Patient Reported ◽

Basal Bolus

Download Full-text

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

Diabetes ◽

10.2337/db20-2192-pub ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 2192-PUB

Author(s):

STEWART B. HARRIS ◽

FRANK J. SNOEK ◽

LUIGI MENEGHINI ◽

FELIPE LAUAND ◽

JUKKA WESTERBACKA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Randomized Controlled Trials ◽

Real World ◽

Basal Insulin ◽

Treatment Satisfaction ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Clinical Research of Insulin Glargine U300 basal‐bolus therapy and Insulin Degludec/Aspart Co‐Formulation in Type 2 Diabetes Mellitus: A Real World Experience (CRIGDA Study)

International Journal of Clinical Practice ◽

10.1111/ijcp.14377 ◽

2021 ◽

Author(s):

Savas Volkan Kisioglu ◽

Ahmet Suat Demir ◽

Damla Tufekci ◽

Yasemin Emur Gunay ◽

Hulya Coskun ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Clinical Research ◽

Insulin Glargine ◽

Real World ◽

Insulin Degludec ◽

Basal Bolus

Download Full-text